Crohn’s and Colitis Canada Awards $2.8M in IBD Research Projects

Crohn’s and Colitis Canada Awards $2.8M in IBD Research Projects
In hopes of finding new treatments and developing programs to aid Canadians with inflammatory bowel disease (IBD), Crohn’s and Colitis Canada is granting $2.8 million to 11 teams of scientists. The annual donor-funded awards are granted to those projects with the most potential to produce new therapies for the 270,000 Canadians who have Crohn’s disease or ulcerative colitis — the main forms of IBD, the organization said. By 2030, the number of patients in Canada is projected to exceed 400,000. “Canada has among the highest rates of Crohn’s disease and ulcerative colitis in the world, and we are determined to drive discovery, the only way to prevent and cure these chronic and debilitating diseases,” Mina Mawani, president and CEO of Crohn’s and Colitis Canada, said in a press release. Each year, IBD costs Canada $2.6 billion. The disease also takes a toll on the quality of life of patients, who are twice as likely as the general population to develop depression and anxiety. For researchers, disparate challenges are growing in urgency: while older adults are experiencing the fastest climb in disease rates, the number of cases in children have increased by more than 50% within the last decade. The high incidence rates led to Crohn’s and Colitis Canada's Grants-in-Aid funding program, which awards scientists and their teams $125,000 annually for three years. Recipients of Innovation Awards get $50,000 for one year. The grants-in-aid program helps advance health policy and IBD prevention efforts, plus searches for treatments and cures. Innovations grants support new or innovative approaches to IBD research. “Our competition is open to all types of research, and a collective review team built with scientific experts, nurses and people livi
Subscribe or to access all post and page content.